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The reaction between the heteroaromatic N-oxides 1a, 1b and 1c with dimethyl acetylenedicarboxylate
or methyl propiolate furnishes 1,3-benzodiazepines, the products of ring transformations of primarily
formed cycloadducts. The structures of 8a and 10a have been confirmed by X-ray crystallographic
analysis. The aldonitrone 1c also reacts with N-methylmaleimide and with phenyl vinyl sulfone to
furnish the first examples of primary cycloaddition products from quinazoline 3-oxides.
Introduction
Nitrone cycloaddition chemistry is a key tool for the synthesis of
natural products andbiologically important synthetic compounds.
Developments in this area continue apace with annulation to
cyclic nitrones being particularly useful. The variety of nitrone and
dipolarophilic components, as well as the complex rearrangement
pathways available to primary cycloadducts, renders the reaction
attractive for the building of a wide range of heterocyclic systems
not readily obtained by other means.1 Whilst 1,3-dipolar cy-
cloadditions to a range of heteroaromatic N-oxides have received
varying amounts of attention, additions to quinazoline derivatives
have had scarce mention in the literature. A single paper dating
from 1972 describes the addition of acetylenedicarboxylate esters
to quinazoline 3-oxides 2;2 two further papers report the addition
of the same dipolarophiles to quinazoline 3-methylides.3,4 In all
cases the isolated products were the products of ring transfor-
mation reactions on the primary cycloadducts. Thus, addition to
the quinazoline 3-oxide 2, studied in benzene with (m)ethanol as
cosolvent, afforded, after purification on basic alumina, the phenyl
acrylates 3 (13–21%) and the benzodiazepines 4 (5–14%) together
with smaller amounts of other products.
Results and discussions
The quinazoline 3-oxide 1b failed to be trapped by alkene
dipolarophiles, dimethyl fumarate (18 h, toluene, 110 ◦C) or
(m)ethyl acrylate even following heating in the absence of a
solvent, and in each case the starting material was returned
unchanged. Neither could any cycloaddition products be found
following heating of a solution of 1b with N-methyl maleimide (2
equivalents) to reflux in any of THF, MeCN or toluene. Attempts
to coerce reactivity by heating 1b with N-phenyl maleimide (5
equivalents) in boiling xylene flagged the thermal instability of
1b. Thus, separation of the reaction mixture provided two new
products. On the basis of their NMR spectral data alone, these
compounds are tentatively assigned as the deoxygenated nitrone
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5 (13%) and the addition product 6 (13%). The latter may
arise from an ene reaction between N-phenylmaleimide and 4-
methylquinazoline 5. In particular, in the 1H NMR spectrum of
5 the C-4 methyl protons resonate at 2.98 ppm, (CDCl3). The
downfield shift in this resonance with respect to the corresponding
protons in 1b (2.40 ppm, C6D6)5a and the reported resonance of
the methyl protons of 4-methylquinazoline at 2.94 ppm (CDCl3)5b
is in keeping with the suggested structure. The diastereomeric
protons, Ha and Ha′ of 6 resonate as doublets of doublets (3.09
and 3.21 ppm). Literature support for these proposals lies with
the known deoxygenation of aromatic N-oxides in boiling xylene6
and with the reported reaction between 2-methylquinoxalines
and maleimides, furnishing, by way of their enamine tautomers,
products parallel to 6.7
The reaction between the 4-methyl-2-styrylquinazoline 3-oxide
1a and dimethyl acetylenedicarboxylate (2 equivalents) reached
completion after 16 h heating in refluxing anhydrous THF. 1H
NMR spectral analysis of the crude reaction mixture suggested
the formation of a single product in almost quantitative yield,
yet purification by flash column chromatography on silica gel
furnished a disappointingly small product yield (36%). Analogous
findings were made following the reaction of the allyl substituted
dipole 1b under the same conditions and a single product was
isolated in 34% yield from a crude reaction mixture which
appeared to contain no other materials. Independent stirring of
the crude products from either reaction in a slurry of silica gel in
the column eluting solvent (6 h, rt) suggested very little change
in composition, accordingly, we have no good explanation for the
poor isolated yield of these adducts.
The 1H NMR spectra of the isolated adducts were not inconsis-
tent with the structure of the proposed primary cycloaddition
products 7a/b, however, following crystallisation from diethyl
ether–hexane the product structure was unambiguously identi-
fied by X-ray crystallographic analysis as having the 5H-1,3-
benzodiazepine framework 8 (Fig. 1). Thermal lability of D4-
isoxazolines is well known8 and it has previously been demon-
strated that the products isolated from the reaction between dialkyl
acetylenedicarboxylates and related heteroaromatic N-oxides viz.
pyrimidine N-oxides,9 quinoline N-oxides,10 isoquinoline N-
oxides,11 and phthalazine N-oxides12 arise by ring transformation
of initially formed 1,3-dipolar cycloaddition products. Only in the
case of the quinoxaline 4-oxides 9 has the primary cycloadduct
2408 | Org. Biomol. Chem., 2006, 4, 2408–2416 This journal is © The Royal Society of Chemistry 2006
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Fig. 1 X-Ray projection of 8a. Ellipsoids represent 40%probability levels.
been characterised.13 Themechanism speculated for the formation
of 8a/b is based on the assumption that the diazepine skeleton
arises from 7a/b by way of a cyclopropyl intermediate as shown
in Fig. 2. Interestingly, in the 1H NMR spectrum of both adducts
8a/b all resonance signals were sharply resolvedwith the exception
of the signal representing the imino methyl protons (2.56 and
2.47 ppm respectively) suggesting a degree of conformational
mobility for the 7-membered ring at rt.
The 5H-1,3-benzodiazepine bicyclic skeleton of 8 is rare in
the literature; Strauss’ access to this skeleton is demonstrated
in the formation of 4,2 Malamidou-Xenikaki et al. have shown
two further routes viz. reductive cyclisation of the isoxazoline
formed by nitrile oxide cycloaddition to 2,3,3-trimethyl-3H-indole
or intramolecular cyclisation between appropriately positioned
amidinium and carbonyl functionalities.14 The product of ring
expansion of 2-quinolinyl imidogen is characterised as the 2H-
tautomer of the same bicyclic skeleton.15 The determination of 8a
represents the first X-ray crystal structure of this bicyclic skeleton.
In an effort to improve the isolated yields of 8a/b purification
of the reaction products on alumina was considered; control
experiments to establish the stability of the 1,3-benzodiazepines on
alumina supports indicated decomposition to complex mixtures
following stirring in a slurry of either acidic or basic alumina
and clean conversion to one new product on neutral alumina.
The reactions between dimethyl acetylenedicarboxylate and the
quinazoline 3-oxides 1a/b were repeated and the products were
isolated following chromatography over neutral alumina.
The product arising from reaction of 1a formed cubic crys-
tals from ether–hexane and an X-ray crystal structure analysis
Fig. 2 Proposed mechanism for the rearrangement of the tricycles 7 to the benzodiazepines 8.
This journal is © The Royal Society of Chemistry 2006 Org. Biomol. Chem., 2006, 4, 2408–2416 | 2409
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determined it to be the 5-methoxycarbonyl-5H-1,3-benzodia-
zepine 5H-10a (30%) (Fig. 3). Its origin from 8a, outlined in Fig. 4,
is presumed to involve hydrolysis of the a-ketocarbomethoxy
group on the chromatographic support. Ready hydrolysis of
dialkyl a-oxosuccinates to methyl acetates has previously been
noted.16 Whilst the X-ray data of 5H-10a shows prototropy is
suppressed in the crystalline state rapid prototropic equilibrium is
evident in solution. In the 1HNMRspectrumof 10a (rt) themethyl
protons of the imine functionality appear at 2.39 (major) and
2.32 ppm (minor tautomer) whilst the resonance of the methoxy
protons is seen at 3.47 (major) and 3.74 ppm (minor tautomer). A
sharp signal at 4.65 ppm is suggestive of a CH rather than an NH
resonance and thus 5H-10a is believed to be the major component
in solution. This is in keeping with Stauss’ estimation that the
5H-isomer represents at least 90% of the tautomeric mixture of
the 2,4,5-trisubstituted benzodiazepine 4.2 Variable temperature
1H NMR spectra indicate an enhanced preference for the 5H-
tautomer as the probe temperature is decreased from 0 ◦C to
−25 ◦C to −50 ◦C.
Fig. 3 X-Ray projection of 10a. Ellipsoids represent 40% probability
levels.
Fig. 4 Proposed mechanism for the hydrolysis of 8 and the tautomeric
equilibria of the resulting benzodiazepines 10.
The relationship between 5H-10a and the possible minor
tautomers, 1H- and 3H-10a is shown in Fig. 4. It is difficult to
unambiguously assign the structure of the minor tautomer, there
are conflicting literature reports on the dominance of 1H- over
3H-tautomers for N-unsubstiuted benzodiazepines. One group
has suggested that 1H-isomers are unstable and isomerise rapidly
to the 3H-isomers;17,18 yet another group characterise related
compounds as 1H-isomers.19,20 Thermal 1,3-sigmatropic H-shifts
are disallowed processes, however, isomerisation between 1H-
and 3H-isomers could be possible through intermolecular proton
exchange between neighbouring hydrogen bonded benzodiazepine
molecules as is presented as an argument for the exchange of H
between N-1 and N-3 of monocyclic diazepines.21 On the basis
of these literature reports and the spectral data available for
10 it is impossible to conclude unambiguously whether the N-
unsubstituted tautomer is the 1H- or the 3H-isomer.
The product isolated from the reaction of 1b with dimethyl
acetylenedicarboxylate following chromatographic separation on
alumina displays analogous spectral characteristics and conse-
quently is formulated as 10b (32%).
Silica gel and alumina are not inert chromatography supports
for compounds with a variety of structural features, and in par-
ticular, imine–enamine isomerisation on these supports is known.
Isolation of hydrolysis products from attempted purification of
enamines on silica gel has also been observed.22 Our observation
that hydrolysis of 8a/b to 10a/b is facile on alumina but not on
silica gel is suggestive of a greater availability of surface hydroxyl
groups on the former.
Reaction between the dipoles 1a/b and methyl propiolate (4
equivalents) reached completion after 48 h stirring in boiling
anhydrous THF. Inspection of the 1H NMR spectral data of the
crude reaction mixtures in each case suggested conversion to one
new product with a high degree of selectivity. Significantly, for
each dipole chromatographic separation of the reaction mixture
on either silica gel or on neutral alumina afforded only one major
product, a species which was not present in the crude samples. The
1HNMR spectra of the isolated adducts were identical to those of
10a and 10b respectively. Isolated yields from chromatography on
Al2O3 were superior to those resulting from purification on SiO2
when much decomposed material was found.
It is speculated that 10a/b form from 1a/b andmethyl propiolate
by way of the benzodiazepines 8c/d. The regiochemical preference
for the addition of methyl propiolate to nitrones is for the
formation of 4-substituted isoxazoline rings,23 thus 7c/d are
proposed as the primary cycloaddition products. Ring expansion
to the benzodiazepines 8c/d followed by attack on the methyl
formylacetate moiety and elimination of HCO2H furnishes 10a/b.
Loss of a formyl group from a formylacetate moiety has been
proposed previously.8
The observation that 10a/b result from chromatography over
either SiO2 or Al2O3 reflects a more facile attack on the formyl
group of 8c/d with respect to the a-oxoester group of 8a/b.
Whilst the isoxazolo[2,3-c]quinazoline tricycle has previously
been formed from a cyclocondensation reaction of 4-methyl-
thioquinazoline 3-oxides with active methylene compounds,24
aldonitrones from the quinazoline 3-oxide series have never before
been the subject of a dipolar cycloaddition study. The reduced
steric demand about the nitrone moiety encouraged us in persuit
of cycloadducts from trapping of the aldonitrone 1c with olefinic
2410 | Org. Biomol. Chem., 2006, 4, 2408–2416 This journal is © The Royal Society of Chemistry 2006
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Fig. 5 Proposed mechanism for the rearrangement of the tricycles 15 to the tautomeric benzodiazepines 17.
dipolarophiles, viz. phenyl vinyl sulfone or N-methyl maleimide.
The reaction with maleimide was complete in 30 min (rt, THF).
Purification of the reaction products furnished the diastereomeric
cycloadducts 11 (17%) and 12 (54%),NOEdifference spectroscopy
experiments confirmed the relative stereochemistry. Thus for 12
irradiation of H-a resulted in a 6% enhancement on the resonance
signal representing H-b establishing 12 as the product of an endo-
cycloaddition. A 1.5% enhancement between the corresponding
protons of adduct 11 confirms it to have resulted from an exo-
alignment of the reactants in the transition state leading to
cycloadduct formation.
The major isomer 12 was found to be unstable on standing in
solution at room temperature, the rearranged product is tentatively
assigned as the ring opened adduct 13, key NMR spectral data in
support of this structure are shown in the drawing.
The trapping of 1c with phenyl vinyl sulfone progressed more
slowly having reached 50% conversion of nitrone after 24 h heating
in boiling THF. The adduct 14was isolated as a single regioisomer.
A comparison of the NOEDS data for 14 with that obtained for
the isomeric adducts 11 and 12permits the interpretation that a 2%
enhancement on the signal representing H-b following irradiation
of H-a is in keeping with 14 being the product of an exo-addition.
Cycloaddition of aldonitrone 1c to dimethyl acetylenedicar-
boxylate was rapid and after 15 min (THF, rt) the reaction
had reached completion. Following chromatography on either
Al2O3 or SiO2 one product was isolated in 7 and 20% yield
respectively. 1H NMR spectroscopy suggests the product to be a
1,3-benzodiazepine, either 1H- or 3H-17. There are three defining
resonance signals in the spectrum of a fresh sample of this sample
(CDCl3). A singlet at 5.50 ppm represents the enamine proton,
4-H, a singlet at 3.79 ppm represents the methoxy protons and a
downfield resonance at ∼12.80 ppm is characteristic of a strongly
H-bonded NH proton. The mechanistic origin of 1H-/3H-17
likely parallels that of 10a/bwith an initial cycloaddition, yielding
15a, preceding ring expansion to the benzodiazepine 16a. The
aldimine functionality apparently facilitates hydrolysis since 10a/b
is isolable from SiO2 whilst 16a undergoes hydrolysis resulting in
the generation of 1H-/3H-17 (Fig. 5).
After a few minutes in solution the presence of an additional
tautomer is evident with further signals appearing, at 4.35 and
3.76 ppm, in the 1H NMR spectrum of 17. A DEPT-135 13C
NMR spectrum of the equilibratingmixture indicates the presence
of one methylene group, at 42.0 ppm. The tautomeric structure is
therefore theC-4 unsubstituted structure, 4H-17. The formationof
the 4H-tautomer, for which no corresponding tautomer presents
from the keto series, is likely a consequence of the enhanced
stabilisation of 4H-17 due to the more highly substituted double
bond. Since thermal 1,7-sigmatropic hydrogen shifts are not
possible for cyclic systems it seems likely that 4H-17 must arise
from 1H-17. The ratio of tautomers in the equilibrium mixture
at rt is ∼3 : 1 in CDCl3 and ∼3 : 2 in d6-DMSO, in favour of
the 1H- over the 3H-tautomer. Variable temperature 1H NMR
spectra (CDCl3) indicate minimal influence of temperature on the
tautomeric ratio over the temperature range 25 ◦C to −50 ◦C.
This journal is © The Royal Society of Chemistry 2006 Org. Biomol. Chem., 2006, 4, 2408–2416 | 2411
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The aldonitrone 15a also reacted with methyl propiolate. Two
products were isolated. The compound with the lower Rf value,
isolated in 9% yield, was identified as 1H-/3H-17 and its solution
tautomer 4H-17. Higher running material, also a white solid and
also obtained in low yield (5%) was unambiguously identified as
the indole 18 followingX-ray crystallographic analysis, Fig. 6. The
structure had two molecules per asymmetric unit. Rearrangement
of benzodiazepines to indoles has a literature precedent, with
reactions being described under conditions of thermal or acid
activation.25
Fig. 6 X-Ray projection of 18. Ellipsoids represent 40%probability levels.
Conclusions
The investigations into the 1,3-dipolar character of aldo- and
ketonitrones of the quinazoline 3-oxide series have yielded many
interesting results in terms of the nature, and the chemical and the
structural stability of the products isolated. With the ketonitrones
1a/b cycloaddition to olefinic dipolarophiles is not observed; that
this failure to react is due to a steric impediment, is supported
by the observation that the aldonitrone 1c can be trapped both
by phenyl vinyl sulfone and by N-methylmaleimide. In all cases
1,3-benzodiazepines were found as the isolated products from the
trapping of 1with acetylenic dipolarophiles implying a facile rear-
rangement of the primarily formed cycloadducts. We have noted
that the crude reaction products were not always stable to purifica-
tion by column chromatography and that depending on the nature
of the C-4 and C-5 substituents on the diazepine ring hydrolysis
was observed during separation on either or both SiO2 or Al2O3.
Solution phase tautomerism is evident in the benzodiazepines 10
and 17 where the hetero-ring is not fully substituted. The X-ray
analysis of 10a indicates the presence of only the 5H-tautomer
in the solid state whilst the 1H/3H-tautomer is also present in
solution. The equilibration between the tautomers of 17 involves
the 1H/3H- with the 4H-isomer, the apparent shift in tautomeric
preference is in deference to the greater stability associated with
the more highly substituted double bonds in the latter.
Experimental
Melting points were determined on a Stuart Scientific (Bibby)
melting point apparatus and are uncorrected. Elemental analyses
were performed on a CE-440 analytical instrument. 1H and 13C
NMR spectra were recorded using a Bruker NMR spectrometer
operating at 300 MHz for 1H and 75 MHz for 13C nuclei. Data
were recorded at probe temperatures with, unless otherwise stated,
tetramethylsilane as the internal reference and deuterochloroform
as the solvent; J values are given in Hertz. Flash column
chromatography was carried out on silica gel 60 (0.040–0.063 nm)
purchased from Merck. Analytical TLC plates were purchased
from Merck, aluninium backed and coated with silica gel 60
F254 indicator. Samples were located by UV illumination using a
portable UVtec lamp (k, 254 nm) or by the use of iodine staining.
Infrared spectra were recorded on a Perkin Elmer 2000 FT-IR
instrument, samples were prepared as KBr discs. The quinazoline
3-oxides 1 were prepared as described elsewhere.5a
Reaction between 1a and N-phenylmaleimide in boiling
xylene—proposed formation of 5 and 6
A solution of 4-methyl-2-[(1E)-prop-1-enyl]quinazoline-3-oxide
1a (0.10 g, 0.49mmol) andN-phenylmaleimide (0.42 g, 2.45mmol)
was allowed to heat at reflux in xylene (13 cm3) for 24 h. The solvent
was removed under reduced pressure and the crude mixture was
purified by flash column chromatography (SiO2, hexane–ether 7 :
3) affording two products. The first product is tentatively identified
as the addition product 6. dH 1.88 (3H, dd, J = 6.9, 1.8, CH=CH–
CH3); 3.09 (1H, dd, J = 18.2, 5.9, CH of CH2–C=O); 3.21 (1H,
dd, J = 18.2, 9.3, CH of CH2–C=O); 3.66 (1H, m, CH); 3.93 (2H,
m, CH2); 6.65 (1H, m, CH=CH–CH3); 7.12 (1H, dq, J = 15.5,
6.9, CH=CH–CH3); 7.49 (6H, m, ArCH); 7.84 (1H, m, ArCH);
7.95 (1H, m, ArCH); 8.04 (1H, m, ArCH). The second product
is identified as the deoxygenated nitrone, 5. dH 2.98 (3H, s, CH3);
7.38 (4H, m, 3 × ArCH and 1 × CH=CH–Ph); 7.56 (1H, m,
ArCH); 7.65 (2H, m, ArCH); 7.84 (1H, m, ArCH); 7.98 (1H,
d, J = 8.2, ArCH); 8.06 (1H, m, ArCH); 8.16 (1H, d, J =
15.9, CH=CH–Ph). dC 20.9 (CH3); 121.8 (C4a); 124.1 (ArCH);
125.8; 126.6; 127.2; 127.7; 127.6 (ArCH and CH=CH–Ph); 132.6
(ArCH); 135.3 (ArC); 137.2 (CH=CH–Ph); 149.2 (C8a); 159.4
(C4); 166.9 (C2).
Methyl 5-[methoxy(oxo)acetyl]-4-methyl-2-[(E)-2-phenylvinyl]-
5H-1,3-benzadiazepine-5-carboxylate, 8a
From reaction between 1a and dimethyl acetylenedicarboxylate
followed by purification on SiO2. A solution of 4-methyl-2-[(E)-
2-phenylvinyl]quinazoline-3-oxide, 1a, (0.20 g, 0.76 mmol) and
dimethyl acetylenedicarboxylate (0.22 g, 1.52 mmol) was heated
at reflux in dry THF (10 cm3) overnight. The solvent was removed
under reduced pressure and the crude oil was purified by flash
column chromatography over silica gel (hexane–ether 6 : 5). The
title product was isolated as a yellow solid (0.10 g, 36%), mp 114–
117 ◦C (hexane–ether). (C23H20N2O5 requires: C, 68.31; H, 4.98; N,
6.92. Found: C, 68.26; H, 5.17; N, 6.61%.) dH 2.56 (3H, br s, CH3);
3.56 (3H, s, OCH3); 3.89 (3H, s, OCH3); 6.77 (1H, d, J = 16.0,
CH=CHPh); 7.44 (10H,m, 9×ArH,CH=CHPh). dC 25.1 (CH3);
53.2 (OCH3); 53.5 (OCH3); 71.1 (C5); 122.1 (C5a); 126.5 (ArCH);
126.9 (CH=CHPh); 127.7, 127.8, 128.8, 129.3, 129.7, 135.6, (9 ×
ArCH); 138.8 (CH=CHPh); 144.2 (C9a); 159.4 (COCO2CH3);
163.1 (CO2CH3); 166.1 (C2, C4); 181.9 (COCO2CH3). IR: t =
1767.5, 1743.8, 1726.5 (CO).
X-Ray crystal determination of 8a†. The structure was solved
by direct methods, SHELXS-97,26 and refined by full matrix
†CCDC reference numbers 298840, 602119 and 602120. For crystallo-
graphic data inCIF or other electronic format seeDOI: 10.1039/b602423h
2412 | Org. Biomol. Chem., 2006, 4, 2408–2416 This journal is © The Royal Society of Chemistry 2006
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Table 1 Crystal data and structure refinement for 8a
Identification code fhm1
Empirical formula C23H20N2O5
Formula weight 404.41
Temperature 298(2) K
Wavelength 0.71069 A˚
Crystal system Triclinic
Space group P-1
Unit cell dimensions a = 7.5822(15) A˚, a = 90.275(9)◦
b = 10.3689(13) A˚, b = 101.461(11)◦
c = 13.0588(9) A˚, c = 100.074(13)◦
Volume 989.9(2) A˚3
Z 2
Density (calculated) 1.357 Mg m−3
Absorption coefficient 0.097 mm−1
F(000) 424
Crystal size 0.46 × 0.44 × 0.36 mm
Theta range for data collection 1.59 to 20.86◦.
Index ranges −7 ⇐ h ⇐ 7; −10 ⇐ k ⇐ 10; −12
⇐ l ⇐ 13
Reflections collected 3934
Independent reflections 1920 [R(int) = 0.0579]
Reflections observed (>2r) 1684
Data completeness 0.918
Absorption correction None
Refinement method Full-matrix least-squares on F 2
Data/restraints/parameters 1920/0/274
Goodness-of-fit on F 2 1.035
Final R indices [I > 2r(I)] R1 = 0.0473, wR2 = 0.1182
R indices (all data) R1 = 0.0534, wR2 = 0.1234
Largest diff. peak and hole 0.164 and −0.194 e A˚−3
R indices; R1 = [R‖F o| − |F c‖]/R|F o| (based on F), wR2 = [[R w(|F o2 −
F c2|)2]/[R w(F o2)2]]1/2 (based on F 2). w = 1/[(rF o)2 + (0.0571×P)2 +
0.22×P]. Goodness-of-fit = [R w(F o2 − F c2)2/(Nobs − Nparameters)]1/2.
least squares using SHELXL-97.27 SHELX operations were
automated using OSCAIL which was also used to obtain the
drawings.28 The XDS program was used for data reduction and
the data was corrected for Lorentz and polarization effects but
not for absorption.29 Hydrogen atoms were included in calculated
positions with thermal parameters 30% larger than the atom to
which they were attached. The non-hydrogen atoms were refined
anisotropically. All calculations were performed on a Pentium
PC. Details of the data collection, solutions, and refinements are
given in Table 1.
Methyl 4-methyl-2-[(E)-2-phenylvinyl]-5H-1,3-benzodiazepine-5-
carboxylate, 10a
(i) From the reaction between 1a and dimethyl acetylenedicar-
boxylate followed by purification on Al2O3. The reaction was
repeated as above on a scale of 1.5 and the crude oil was purified
by column chromatography over neutral alumina, (hexane–ether
6 : 5). The title compound was isolated as a yellow solid (0.12 g,
30%), mp 134–137 ◦C (hexane–ether). (C20H18N2O2 requires: C,
75.45; H, 5.69; N, 8.79. Found: C, 75.27; H, 5.79; N, 8.79%). dH
2.32 (0.6H, br s, CH3 taut); 2.39 (2.4H, s, CH3 taut); 3.47 (2.4H, s,
OCH3 taut); 3.74 (0.6H, br s, OCH3 taut); 4.65 (0.80H, s, CH
taut); 6.84 (1H, d, J = 16.0, CH=CHPh); 7.88 (10H, m, 9 ×
ArH, CH=CHPh). dC 26.9 (CH3); 52.6 (OCH3); 57.1 (C5); 124.8
(C5a); 127.0 (CH=CHPh); 127.3, 127.7, 127.8, 128.7, 128.8, 129.0,
129.3 (9 × ArCH); 136.0 (ArC); 138.5 (CH=CHPh); 144.4 (C4a);
159.4 (C=O); 165.7 (C2); 167.5 (C4). IR: t = 3055.9 (NH); 2954.7
(CH=CH); 1732.6 (CO2CH3).
(ii) From the reaction between 1a and methyl propiolate followed
by purification on either (a) SiO2 or (b) neutral Al2O3. A solution
of 1a (0.20 g, 0.76 mmol) and methyl propiolate (0.26 g, 3.04
moles) was heated at reflux in dry THF (15 cm3) overnight. The
solvent was removed under reduced pressure and the crude oil was
purified by column chromatography according to either (a) or (b)
below.
(a) Purification over silica gel. The product 10a, eluted from
hexane–ether (6 : 5) as the mobile phase, was obtained as a yellow
solid (0.06 g, 23%).
(b) Purification over neutral alumina. The product 10a, eluted
using hexane–ether (6 : 5), was obtained as a yellow solid (0.19 g,
60%).
X-Ray crystal determination of 10a†. Single crystals were
analyzed using a Nonius Kappa CCD diffractometer. Details of
the data collection, solutions, and refinements are given in Table 2.
The model was solved and subsequently refined using full-matrix
least squares in SHELXL-9730
Methyl 5-[methoxy(oxo)acetyl]-4-methyl-2-[(1E)-prop-1-enyl]-5H-
1,3-benzodiazepine-5-carboxylate, 8b
From the reaction between 1b and dimethyl acetylenedicarboxy-
late followed by purification on SiO2. A solution of 4-methyl-
2-[(1E)-prop-l-enyl]quinazoline-3-oxide, 1b, (0.16 g, 0.77 mmol),
and dimethyl acetylenedicarboxylate (0.22 g, 1.54 mmol) was
heated at reflux in dry THF (10 cm3) overnight. The solvent
was removed under reduced pressure and the crude oil was
purified by flash column chromatography (SiO2, hexane–ether,
1 : 1). The pure product was isolated as a yellow solid (0.09 g,
Table 2 Crystal data and structure refinement for 10a
Identification code h04pma2
Empirical formula C20H18N2O2
Formula weight 318.36
Temperature 150(2) K
Wavelength 0.71073 A˚
Crystal system Triclinic
Space group P-1
Unit cell dimensions a = 7.4920(1) A˚, a = 73.159 (1)◦
b = 9.0450(2) A˚, b = 73.945(1)◦
c = 13.5630(4) A˚, c = 70.568(1)◦
Volume 812.88(3) A˚3
Z 2
Density (calculated) 1.301 Mg m−3
Absorption coefficient 0.085 mm−1
F(000) 336
Crystal size 0.50 × 0.50 × 0.50 mm
Theta range for data collection 3.62 to 27.57◦
Index ranges −9 ⇐ h ⇐ 9; −11 ⇐ k ⇐ 11;
−17 ⇐ l ⇐ 17
Reflections collected 14444
Independent reflections 3688 [R(int) = 0.0283]
Reflections observed (>2r) 3052
Data completeness 0.980
Absorption correction None
Refinement method Full-matrix least-squares on F 2
Data/restraints/parameters 3688/0/220
Goodness-of-fit on F 2 1.031
Final R indices [I > 2r(I)] R1 = 0.0381, wR2 = 0.0922
R indices (all data) R1 = 0.0488, wR2 = 0.0982
Largest diff. peak and hole 0.226 and −0.192 e A˚−3
This journal is © The Royal Society of Chemistry 2006 Org. Biomol. Chem., 2006, 4, 2408–2416 | 2413
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34%), mp 100–103 ◦C (hexane–ether). (C18H18N2O5 requires: C,
63.15; H, 5.30; N, 8.19. Found: C, 63.14; H, 5.25; N, 8.39%.)
dH 1.91 (3H, d, J = 6.4, CH=CHCH3); 2.47 (3H, s, CH3);
3.71 (3H, s, OCH3); 3.88 (3H, s, OCH3); 6.11 (1H, d, J =
15.6, CH=CHCH3); 6.69 (1H, m, CH=CHCH3); 7.41 (4H, m,
ArH). dC 18.4 (CH=CHCH3); 25.0 (N=CCH3); 53.2 (OCH3);
53.5 (OCH3); 70.8 (C5); 122.0 (C5a); 126.4 (ArCH); 127.5
(ArCH); 128.7 (ArCH); 129.6 (ArCH); 130.5 (CH=CHCH3);
138.1 (CH=CHCH3); 144.1 (C9a); 159.4 (COCO2CH3); 161.2
(CO2CH3); 166.1 (C2, C4); 181.7 (COCO2CH3). IR: t = 1758.8,
1740.8, 1732.1 (C=O).
Methyl 4-methyl-2-[(1E)-prop-1-enyl]-5H-1,3-benzodiazepine-5-
carboxylate, 10b
(i) From the reaction between 1b and dimethyl acetylenedicar-
boxylate followed by purification on Al2O3. A solution of 1b
(0.20 g, 0.99 mmol), and dimethyl acetylenedicarboxylate (0.28 g,
1.99 mmol) was heated at reflux in dry THF (10 cm3) overnight.
The solvent was removed under reduced pressure and the crude
oil was purified by column chromatography over neutral alunina
(hexane–ether, 7 : 3). A single productwas isolated as a yellow solid
(0.09 g, 32%), mp 73–77 ◦C (hexane–ether). (C15H16N2O2·2H2O
requires: C, 61.63; H, 6.80; N, 9.50. Found: C, 61.29: H, 6.33;
N, 9.00%.) dH 1.93 (3H, dd, J = 6.9, 1.5, CH3); 2.25 (0.5H, br s,
CH3 taut); 2.32 (2.5H, s, CH3 taut); 3.50 (2.5H, s, OCH3 taut);
3.85 (0.5H, br s, OCH3 taut); 4.59 (0.82H, s, CH taut); 6.17
(0.82H, m, CH=CHCH3 taut); 6.21 (0.18H, m, CH=CHCH3
taut); 6.77 (1H, dq, J = 15.5, 6.9, CH=CHCH3); 7.17 (1H, d,
J = 7.5, ArH); 7.29 (1H, m, ArH); 7.42 (2H, m, ArH). dC 18.4
(CH=CHCH3); 26.8 (CH3); 52.5 (OCH3); 57.5 (C5); 124.9 (C5a);
126.9 (ArCH); 127.6 (ArCH); 128.7 (ArCH); 129.2 (ArCH); 130.5
(CH=CHCH3); 137.7 (CH=CHCH3); 144.3 (C9a); 159.2 (C=O);
165.2 (C2); 167.7 (C4). IR: t = 3426.7 (NH); 1731.4 (C=O).
(ii) From the reaction between 1b and methyl propiolate followed
by purification on either (a) SiO2 or (b) neutral Al2O3. A solution
of 1b (0.20 g, 0.99mmol) andmethyl propiolate (0.33 g, 3.99mmol)
was heated at reflux in dry THF (14 cm3) for 48 h. The solvent was
removed under reduced pressure and the crude oil was purified by
column chromatography according to either (a) or (b) below.
(a) Purification over silica gel. The product 10b, eluted from
hexane–ether (6 : 5) as the mobile phase, was obtained as a yellow
solid (0.02 g, 7%).
(b) Purification over neutral alumina. The product 10b, eluted
using hexane–ether (6 : 5) as the mobile phase, was obtained as a
yellow solid (0.16 g, 54%).
10-Methyl-6-[(E)-2-phenylethenyl]-11a,11b-
dihydropyrrolo[3′,4′:4,5]isoxazolo[2,3-c]quinazoline-
9,11(8aH ,10H)-diones 11 and 12 and 3-hydroxy-1-methyl-4-
{2-[(E)-2-phenylethenyl]-3,4-dihydro-4-quinazolinyl}-1H-pyrrole-
2,5-dione 13
A solution of 1b and N-methylmaleimide (0.22 g, 1.62 mmol)
in dry THF (25 cm3) was allowed to stir at rt for 30 min. The
solventwas removedunder reducedpressure and the crudemixture
was purified by flash column chromatography (SiO2, hexane–ether,
1 : 1).
12 (0.49 g, 17%), a yellow solid, mp 133–134 ◦C (hexane–ether).
(C21H17N3O3 requires: C, 70.18;H, 4.77;N, 11.69. Found: C. 69.96;
H, 4.22; N, 11.54%.) dH (acetone) 2.86 (3H, s, N–CH3); 3.74 (1H,
dd, J = 7.8, 7.8, H-b); 4.77 (1H, d, J = 7.8, H-a); 4.90 (1H, d,
J = 8.1, H-c); 7.12 (3H, m, ArH and CH=CH–Ph); 7.28 (5H, m,
ArH); 7.61 (2H, m, ArH); 7.70 (1H, d, J = 16.0, CH=CH–Ph).
dC (acetone) 25.6 (N–CH3); 58.6 (C11a); 62.7 (C11b); 80.1 (C8a);
119.1 (CH=CH–Ph); 125.4 (ArC); 127.4 (ArCH); 127.7 (ArCH);
128.4 (ArCH); 128.9 (ArC); 129.1 (ArCH); 130.2 (ArCH); 130.8
(ArCH); 130.8 (ArCH); 137.0 (ArCN); 140.3 (CH=CH–Ph);
157.2 (N=CN); 171.9 (C=O); 174.8 (C=O). IR: t = 1712.7
(C=O); 1630.0 (C=C); 1556.8 (C=N). NOEDS results for 12:
irradiation of H-c caused a 6.3% enhancement onH-b; irradiation
of H-a caused enhancements on H-b (3.1%) and on ArH (2.8%),
irradiation of H-b caused the following enhancement, 7.3% on
H-c.
11 (0.16 g, 54%), yellow solid, mp 110–112 ◦C (hexane–ether).
dH (acetone) 2.47 (3H, s, N–CH3); 3.95 (1H, dd, J = 7.1, 7.5, H-
b); 4.95 (1H, d, J = 7.5, H-a); 5.06 (1H, d, J = 7.1, H-c); 6.93
(1H, d, J = 15.6, CH=CH–Ph); 7.05 (2H, m, ArH); 7.25 (5H, m,
ArH); 7.49 (2H, m, ArH); 7.57 (1H, d, J = 15.9, CH=CH–Ph).
dC (acetone) 25.3 (N–CH3); 54.9 (C11a); 62.9 (C11b); 79.7 (C8a);
119.2 (CH=CH–Ph); 123.3 (C1a); 126.9 (ArCH); 127.4 (ArCH);
128.9 (ArCH); 129.1 (2 × ArCH); 130.1 (2 × ArCH); 130.6
(ArCH); 130.7 (ArCH); 137.2 (ArC); 139.5 (CH=CH–Ph); 141.5
(C4a); 157.5 (C6); 173.3 (C=O). IR: t = 1712.7 (C=O); 1630.0
(C=C); 1556.8 (C=N). NOEDS results for 11: irradiation of H-c
caused a 6.2% enhancement on H-b; irradiation of H-a caused
enhancements on H-b (6.3%) and on ArH (4.6%), irradiation of
H-b caused the following enhancements, 6.9% on H-c and 6.8%
on H-a.
13 dH 3.11 (3H, s, N–CH3); 5.28 (1H, s, CH); 6.90 (1H, d,
J = 14.5, CH=CH–Ph); 7.34 (4H, m, ArH); 7.56 (5H, m, ArH
and CH=CH–Ph), 8.40 (1H, d, J = 8.3, ArH); 13.00 (1H, br s,
NH/OH). dC 24.3 (N–CH3); 68.2 (CH); 77.2 (CH=CH–Ph); 127.3,
127.9, 128.0, 129.0, 130.1, 134.1 (9 x ArCH and CH=CH–Ph);
118.1 (ArC); 121.1 (C1a); 127.7 (C4a); 128.8 (C6); 137.4 (C–
C(O)); 149.2 (C–OH); 173.1 (C=O); 175.7 (C=O). IR: t = 3424.7
(OH/NH); 1749.2 (C=O).
5-[(E)-2-phenylethenenyl]-1-(phenylsulfonyl)-1,10b-dihydro-2H-
isoxazolo[2,3-c]quinazoline, 14
A solution of 1a (0.2 g, 0.81 mmol), and phenyl vinyl sulfone
(0.22 g, 1.62 mmol) was heated at reflux in dry THF (30 cm3)
for 24 h. The THF was removed under reduced pressure and
the crude mixture was purified by flash column chromatography
(SiO2, hexane–ether, 7 : 3) to afford a yellow solid (0.08 g, 49%
based on%nitrone consumption), mp 125–127 ◦C (hexane–ether).
(C24H20N2SO3 requires: C, 69.21; H, 4.84; N, 6.70; S, 7.69. Found:
C, 68.87; H, 4.86; N, 6.65; S, 7.78%.) dH 3.73 (1H, dd, J = 9.9,
9.9, HC–CH2–O); 4.05 (1H, m, H-c); 4.42 (1H, dd, J = 9.9, 9.9
HC–CH2–O); 5.22 (1H, d, J = 6.7, Hd); 6.99 (1H, d, J = 16.0,
CH=CH–Ph); 7.11 (1H, m, ArH); 7.32 (5H, m, ArH); 7.57 (4H,
m, ArH); 7.69 (1H, m, ArH); 7.76 (1H, d, J = 16.0, CH=CH–
Ph); 7.93 (2H, m, ArH). dC 59.3 (Ph–CH–N); 69.9 (CH2); 74.0
(CH, m); 117.9 (CH=CH–Ph); 122.4 (ArC–CHd); 126.4 (ArCH);
126.4 (ArCH); 127.8 (2 × ArCH); 127.9 (ArCH); 128.7 (2 ×
ArCH); 128.8 (2 × ArCH); 129.5 (ArCH); 129.8 (ArCH); 129.8
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(2 × ArCH); 134.6 (ArCH); 135.5 (ArC); 138.0 (ArC–N); 139.3
(ArC=N); 139.6 (CH=CH–Ph). IR: t = 3062.5 (CH=CH); 1636.7
(C=C); 1559.0 (C=N); 1357.1 (SO2).NOEDS results for 14:
irradiation of H-b caused the following enhancements, 22.5% on
H-a, 6.4% on H-c and 2.9% on ArH; irradiation of H-c caused
enhancements on Hd (2.0%), H-b (3.8%) and on ArH (4.3%),
irradiation of H-a caused the following enhancements, 20.1% on
H-b, 1.1% on Hd, 0.6% on H-c and 5.2% on ArH; irradiation of
Hd caused enhancements on H-c (1.8%) and on ArH (7.2%).
Methyl 2-[(E)-2-phenylvinyl]-5H-1,3-benzodiazepine-5-
carboxylate 17
(i) From the reaction between 1c and dimethyl acetylenedicar-
boxylate following purification on (a) SiO2 or (b) Al2O3. (a) A
solution of 2-[(E)-2-phenylvinyl]quinazoline-3-oxide 1c (0.10 g,
0.40 mmol) and dimethyl acetylenedicarboxylate (0.12 g, 0.80
mmol) was allowed to stir at rt for 15min in dry THF (10 cm3). The
THF was removed under reduced pressure and the crude product
was purified by flash column chromatography over SiO2 (hexane–
ether, 7 : 3) to afford a yellow solid (0.03 g, 20%), mp 104–106 ◦C
(hexane–ether). (C19H16N2O2 requires: C, 74.98; H, 5.29; N, 9.20.
Found: C, 74.37; H, 5.32; N, 8.95%.) dH 3.76 (0.75H, s, OCH3
taut); 3.79 (2.25H, s, OCH3 taut); 4.35 (0.5H, s, CH2 taut); 5.50
(0.75H, s, =CH–N taut); 6.86 (0.75H, d, J = 16.3, =CH); 7.36
and 7.62 (8.5H, 2 × m, ArH and =CH taut); 7.73 (0.75H, d, J =
7.5, ArCH taut); 7.85 (0.25H, m, ArH taut); 7.99 (0.5H, m, 2 ×
ArH taut); 8.15 (0.25H, d, J = 16.3, =CH); 12.80 (0.75H, br s,
NH taut). dC 42.0 (CH2 minor taut); 51.3 (OCH3 major taut); 52.9
(OCH3 minor taut); 78.5 (=CH–N major taut); 122.3 (CH alkene
major taut); 123.6, 126.5, 127.6, 128.1, 128.2, 128.4, 129.3, 129.4,
130.2, 135.5, 137.9, 139.1 (9 × ArCH, CH alkene major, 2 × CH
alkene minor); 125.5, 129.2, 134.3 (3 × ArCH taut); 119.6 (C5a
major); 135.4, 146.0, 149.5, 150.6, 151.3, 160.9 (ArC); 170.1, 171.2
(2 × CO2CH3). IR: t = 3080.9 (NH); 2940.7 (CH=CH); 1750.9
(CO2CH3).
(b) The reaction was repeated with a three fold scale-up and
the crude mixture was purified by column chromatography over
Al2O3 (hexane–ether, 8 : 2) to afford the same yellow solid (0.03 g,
7%).
(ii) From the reaction between 1c and methyl propiolate. A
solution of 1c (0.20 g, 0.81 mmol) and methyl propiolate (0.13 g,
1.62 mmol) was heated at reflux in dry THF (25 cm3) for 2 h.
The THF was removed under reduced pressure and the crude
reaction mixture was purified by flash column chromatography
(SiO2, hexane–DCM, 7 : 3). Two products were isolated. Firstly,
methyl 1-[(E)-3-phenyl-2-propenoyl]-1H-indole-3-carboxylate 18,
a white solid, (0.01 g, 5%), mp 108–110 ◦C. (C19H15N1O3 requires
C, 74.74; H 4.95; N, 4.59. Found C, 70.10; H, 4.71; N, 4.18%.)
dH 3.98 (3H, s, OCH3); 7.10 (2H, m, =CH and ArH); 7.45 (4H,
m, ArH); 7.69 (2H, m, ArH); 8.05 (1H, d, J = 15.4, =CH); 8.17
(1H, m, ArH); 8.37 (1H, s, CH); 8.54 (1H, m, ArH). dC 116.1
(1 × ArCH and =CH); 116.7, 121.7, 124.9, 125.9, 128.6, 129.2,
131.3 (7 × ArCH); 113.7 (ArC); 127.5 (C=CH); 130.6 (CH);
134.1 (ArC–N); 136.3 (ArC–C=CH); 148.3 (=CH); 164.3, 164.3
(2 × C=O). The second product isolated was 17, a yellow solid,
(0.02 g, 9%).
Table 3 Crystal data and structure refinement for 18
Identification code fhx
Empirical formula C38H30N2O6
Formula weight 610.64
Temperature 293(2) K
Wavelength 0.71069 A˚
Crystal system Triclinic
Space group P-1
Unit cell dimensions a = 7.4430(10) A˚, a = 82.95(2)◦
b = 10.892(2) A˚, b = 81.14(2)◦
c = 19.212(3) A˚, c = 88.01(2)◦
Volume 1527.1(4) A˚3
Z 2
Density (calculated) 1.328 Mg m−3
Absorption coefficient 0.090 mm−1
F(000) 640
Crystal size 0.35 × 0.30 × 0.20 mm
Theta range for data collection 2.06 to 25.98◦
Index ranges −2 ⇐ h ⇐ 9; −13 ⇐ k ⇐ 13;
−23 ⇐ l ⇐ 23
Reflections collected 7081
Independent reflections 5982 [R(int) = 0.0109]
Reflections observed (>2r) 3370
Data completeness 0.998
Absorption correction None
Refinement method Full-matrix least-squares on F 2
Data/restraints/parameters 5982/0/417
Goodness-of-fit on F 2 1.053
Final R indices [I > 2r(I)] R1 = 0.0410, wR2 = 0.1190
R indices (all data) R1 = 0.0947, wR2 = 0.1417
Largest diff. peak and hole 0.212 and −0.291 e A˚−3
R indices; R1 = [R‖F o| − |F c‖]/R|F o| (based on F), wR2 = [[R w(|F o2 −
F c2|)2]/[R w(F o 2)2]]1/2 (based on F 2). w = 1/[(rF o)2 + (0.0781×P)2].
Goodness-of-fit = [R w(F o2 − F c2)2/(Nobs − Nparameters)]1/2.
X-Ray crystal determination of 18. The structure was solved
by direct methods, SHELXS-97,26 and refined by full matrix least
squares using SHELXL-97.27 SHELX operations were automated
using ORTEX which was also used to obtain the drawings.31
Data were corrected for Lorentz and polarization effects but
not for absorption. Hydrogen atoms were included in calculated
positions with thermal parameters 30% larger than the atom to
which they were attached. The non-hydrogen atoms were refined
anisotropically. All calculations were performed on a Pentium
PC. There were two molecules per asymmetric unit. The unit cell
and its contents were checked for any missed symmetry using the
program CHKSYM and no missed symmetry was found.28 The
two independent molecules differed only by a minor change in
conformation about the N(1)–C(9) bond and a 180◦ difference
in conformation about the C(2)–C(18) bond. Details of the data
collection, solutions, and refinements are given in Table 3.
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